If you liked this article you might like

Week Ahead: Earnings Come in Thick and Fast in a Middling First-Quarter Reporting Season
Here's Why You Should Hope for Panic: Cramer's 'Mad Money' Recap (Friday 4/21/17)
Intermediate Trade: Bristol-Myers Squibb
Takeaways and Observations; The Good, the Bad and the Ugly: Doug Kass' Views